215 related articles for article (PubMed ID: 37176111)
21. High-Throughput Label-Free Isolation of Heterogeneous Circulating Tumor Cells and CTC Clusters from Non-Small-Cell Lung Cancer Patients.
Zeinali M; Lee M; Nadhan A; Mathur A; Hedman C; Lin E; Harouaka R; Wicha MS; Zhao L; Palanisamy N; Hafner M; Reddy R; Kalemkerian GP; Schneider BJ; Hassan KA; Ramnath N; Nagrath S
Cancers (Basel); 2020 Jan; 12(1):. PubMed ID: 31947893
[TBL] [Abstract][Full Text] [Related]
22. Detection and Characterization of Circulating Tumor Associated Cells in Metastatic Breast Cancer.
Mu Z; Benali-Furet N; Uzan G; Znaty A; Ye Z; Paolillo C; Wang C; Austin L; Rossi G; Fortina P; Yang H; Cristofanilli M
Int J Mol Sci; 2016 Sep; 17(10):. PubMed ID: 27706044
[TBL] [Abstract][Full Text] [Related]
23. Prognostic and Therapeutic Significance of Circulating Tumor Cell Phenotype Detection Based on Epithelial-Mesenchymal Transition Markers in Early and Midstage Colorectal Cancer First-Line Chemotherapy.
Lu G; Lu Z; Li C; Huang X; Luo Q
Comput Math Methods Med; 2021; 2021():2294562. PubMed ID: 34777560
[TBL] [Abstract][Full Text] [Related]
24. Cytopathological Study of the Circulating Tumor Cells filtered from the Cancer Patients' Blood using Hydrogel-based Cell Block Formation.
Kang YT; Kim YJ; Lee TH; Cho YH; Chang HJ; Lee HM
Sci Rep; 2018 Oct; 8(1):15218. PubMed ID: 30315187
[TBL] [Abstract][Full Text] [Related]
25. Classification of circulating tumor cells by epithelial-mesenchymal transition markers.
Wu S; Liu S; Liu Z; Huang J; Pu X; Li J; Yang D; Deng H; Yang N; Xu J
PLoS One; 2015; 10(4):e0123976. PubMed ID: 25909322
[TBL] [Abstract][Full Text] [Related]
26. Clinical Relevancy of Circulating Tumor Cells in Breast Cancer: Epithelial or Mesenchymal Characteristics, Single Cells or Clusters?
Fridrichova I; Kalinkova L; Ciernikova S
Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292996
[TBL] [Abstract][Full Text] [Related]
27. Molecular detection of epithelial-mesenchymal transition markers in circulating tumor cells from pancreatic cancer patients: Potential role in clinical practice.
Zhao XH; Wang ZR; Chen CL; Di L; Bi ZF; Li ZH; Liu YM
World J Gastroenterol; 2019 Jan; 25(1):138-150. PubMed ID: 30643364
[TBL] [Abstract][Full Text] [Related]
28. Development and initial clinical testing of a multiplexed circulating tumor cell assay in patients with clear cell renal cell carcinoma.
Bade RM; Schehr JL; Emamekhoo H; Gibbs BK; Rodems TS; Mannino MC; Desotelle JA; Heninger E; Stahlfeld CN; Sperger JM; Singh A; Wolfe SK; Niles DJ; Arafat W; Steinharter JA; Jason Abel E; Beebe DJ; Wei XX; McKay RR; Choueri TK; Lang JM
Mol Oncol; 2021 Sep; 15(9):2330-2344. PubMed ID: 33604999
[TBL] [Abstract][Full Text] [Related]
29. Clinical significance of circulating tumor cells detection in renal cell carcinoma with thrombus: A STROBE-compliant study.
Ge L; Song Y; Yang F; Zhao G; Lu M; Zhang S; Ma L
Medicine (Baltimore); 2020 May; 99(22):e20615. PubMed ID: 32481476
[TBL] [Abstract][Full Text] [Related]
30. Exploring sialyl-Tn expression in microfluidic-isolated circulating tumour cells: A novel biomarker and an analytical tool for precision oncology applications.
Neves M; Azevedo R; Lima L; Oliveira MI; Peixoto A; Ferreira D; Soares J; Fernandes E; Gaiteiro C; Palmeira C; Cotton S; Mereiter S; Campos D; Afonso LP; Ribeiro R; Fraga A; Tavares A; Mansinho H; Monteiro E; Videira PA; Freitas PP; Reis CA; Santos LL; Dieguez L; Ferreira JA
N Biotechnol; 2019 Mar; 49():77-87. PubMed ID: 30273682
[TBL] [Abstract][Full Text] [Related]
31. Detection of circulating tumor cells with a novel microfluidic system in malignant pleural mesothelioma.
Yoneda K; Kuwata T; Chikaishi Y; Mori M; Kanayama M; Takenaka M; Oka S; Hirai A; Imanishi N; Kuroda K; Ichiki Y; Ohnaga T; Tanaka F
Cancer Sci; 2019 Feb; 110(2):726-733. PubMed ID: 30499156
[TBL] [Abstract][Full Text] [Related]
32. Clinical significance of circulating tumour cells and Ki-67 in renal cell carcinoma.
Song J; Yu Z; Dong B; Zhu M; Guo X; Ma Y; Zhao S; Yang T
World J Surg Oncol; 2021 May; 19(1):156. PubMed ID: 34034739
[TBL] [Abstract][Full Text] [Related]
33. The Surge in the Number of Circulating Tumor Cells Following Treatment with Sunitinib for Metastatic Renal Cell Carcinoma.
Nagaya N; Kanayama M; Nagata M; Horie S
Intern Med; 2018 Sep; 57(18):2695-2700. PubMed ID: 29709937
[TBL] [Abstract][Full Text] [Related]
34. Longitudinal Molecular Profiling of Circulating Tumor Cells in Metastatic Renal Cell Carcinoma.
Bootsma M; McKay RR; Emamekhoo H; Bade RM; Schehr JL; Mannino MC; Singh A; Wolfe SK; Schultz ZD; Sperger J; Xie W; Signoretti S; Kyriakopoulos CE; Kosoff D; Abel EJ; Helzer KT; Rydzewski N; Bakhtiar H; Shi Y; Blitzer G; Bassetti M; Floberg J; Yu M; Sethakorn N; Sharifi M; Harari PM; Choueiri TK; Lang JM; Zhao SG
J Clin Oncol; 2022 Nov; 40(31):3633-3641. PubMed ID: 35617646
[TBL] [Abstract][Full Text] [Related]
35. A novel multimarker assay for the phenotypic profiling of circulating tumor cells in hepatocellular carcinoma.
Court CM; Hou S; Winograd P; Segel NH; Li QW; Zhu Y; Sadeghi S; Finn RS; Ganapathy E; Song M; French SW; Naini BV; Sho S; Kaldas FM; Busuttil RW; Tomlinson JS; Tseng HR; Agopian VG
Liver Transpl; 2018 Jul; 24(7):946-960. PubMed ID: 29624843
[TBL] [Abstract][Full Text] [Related]
36. Circulating tumour cells escape from EpCAM-based detection due to epithelial-to-mesenchymal transition.
Gorges TM; Tinhofer I; Drosch M; Röse L; Zollner TM; Krahn T; von Ahsen O
BMC Cancer; 2012 May; 12():178. PubMed ID: 22591372
[TBL] [Abstract][Full Text] [Related]
37. Microfluidic-Based Technologies for CTC Isolation: A Review of 10 Years of Intense Efforts towards Liquid Biopsy.
Descamps L; Le Roy D; Deman AL
Int J Mol Sci; 2022 Feb; 23(4):. PubMed ID: 35216097
[TBL] [Abstract][Full Text] [Related]
38. Affinity Versus Label-Free Isolation of Circulating Tumor Cells: Who Wins?
Murlidhar V; Rivera-Báez L; Nagrath S
Small; 2016 Sep; 12(33):4450-63. PubMed ID: 27436104
[TBL] [Abstract][Full Text] [Related]
39. All-in-one centrifugal microfluidic device for size-selective circulating tumor cell isolation with high purity.
Lee A; Park J; Lim M; Sunkara V; Kim SY; Kim GH; Kim MH; Cho YK
Anal Chem; 2014 Nov; 86(22):11349-56. PubMed ID: 25317565
[TBL] [Abstract][Full Text] [Related]
40. Role of circulating tumor cells in patients with metastatic clear-cell renal cell carcinoma.
Nayak B; Panaiyadiyan S; Singh P; Karmakar S; Kaushal S; Seth A
Urol Oncol; 2021 Feb; 39(2):135.e9-135.e15. PubMed ID: 33250345
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
